Unlike the rearranged antigen-specific receptor genes that are used by the adaptive immune system, natural killer (NK) cells use a variety of germline-encoded gene products for their recognition armament and so are categorized as part of the innate immune system. For quite some time, the primary paradigm describing NK cell killing was the notion of "missing self," 1 especially regarding deficient autologous MHC class I expression. That is, it is clear that the absence or reduction of MHC class I expression permits NK cell activation by transformed or infected cells. However, during the past few years, it has become clear that NK cell recognition involves a broad spectrum of both inhibitory and activating receptor:ligand interactions. Both the activation and inhibition of NK cells predominantly involve interactions with a series of MHC class I and class I-like molecules. 2 Thus, whereas classical MHC class I expression provides the major source of inhibitory signals to NK cells, another series of more unusual, inducible class I-like molecules serve as signals of cellular stress, transformation, and infection.
Many NK receptors are encoded within the NK complex found on mouse chromosome 6 and human chromosome 12p13.2. Several excellent reviews have focused on these receptors and ligands [2] [3] [4] [5] [6] and so are not discussed in great detail. However, there are key concepts regarding NK receptors that should be highlighted. It is important to note that NK cell reactivity is an integrated response controlled by both activating and inhibitory signals (examples of such receptor: ligands are summarized in Table 1 ). NK cell inhibition is achieved by a series of receptors, such as much of the Ly49 family in mice (although some Ly49 receptors are activating) and the killer cell Iglike receptors found on human NK cells. 6 The reduction in self MHC class expression by transformed or infected autologous cells or by MHC-disparate allogeneic cells accounts in part for the "missing self" response by releasing such inhibitory stimuli. However, studies in the past several years have identified another series inducible MHC class I-like stimulating ligands that interact with NK activating ligands, such as NKG2D. 7 Taken together, the absence of self is not sufficient to promote NK cell killing but also requires the expression of appropriate activating ligands on the target cell. It will be an ongoing challenge to dissect the contribution of particular activating and inhibitory NK cell receptors to allograft immunity and tolerance.
Because NK reactivity is affected by both positive and negative signals, NK cells can kill self targets despite the pres-ence of inhibitory MHC class I molecules. For example, the "induced self" retinoic acid early inducible-1 (RAE-1) ligand can trigger the corresponding NK activating NKG2D receptor, resulting in tumor cell killing. 7 Importantly, enforced RAE-1 expression in tumor cells can override inhibitory MHC class I signals and allow NK cell-mediated tumor rejection in vivo. 8 This means that NK cells can regulate autologous cells despite the expression of inhibitory self MHC class I ligands, such as found in NK killing of immature dendritic cells (DC) 9, 10 or "stressed" autologous T cells. 11 This concept will be an important consideration regarding the potential role for NK cells in allograft tolerance induction discussed next.
OVERLAP BETWEEN NK CELLS AND OTHER FORMS OF MHC CLASS I-DEPENDENT IMMUNITY
It is important to emphasize that some of the ambiguity in defining the role of NK cells in allograft immunity and tolerance is due to the overlap of function between NK cells and other types of MHC class I-dependent cells and/or the considerable cross-talk between NK cells and other cells. For example, activated CD8 T cells can express several NK cell-like receptors that can contribute to their effector function. Once activated, human CD8 T cells are capable of tumor cell killing through the NKG2D activating ligand (usually attributed to NK cells) independent of antigen-specific T cell receptor recognition. 12 Also, asialo GM1 is a cell surface marker that often is used to identify and/or target NK cells but is also expressed on an important population of CD8 T cells. 13 Kronenberg 15 ). There are also interactions between NK and NKT cells during the initial innate response to tissue injury or pathogen exposure. However, unlike NK cells, NKT cells express CD3 and a relatively restricted, or "invariant," T cell receptor repertoire restricted to nonclassical CD1 class I molecules presenting glycolipid moieties. Thus, it is not surprising that it is challenging to distinguish NK cellspecific functions from those of other MHC class I-dependent immune pathways.
CONTRIBUTIONS OF NK CELLS TO ACUTE AND CHRONIC ALLOGRAFT INJURY
Although our own interest has focused on the role of NK cells in tolerance induction, it is important to note the multiple contributions of these cells to both acute and chronic graft rejection. NK cells are widely known as mediators of MHC-disparate hematopoietic stem cell rejection 16, 17 and can constitute an important barrier to T cell-directed tolerance protocols for achieving mixed hematopoietic chimerism. 18 With this notable exception of bone marrow allografts, NK cells are not usually either necessary or sufficient to mediate allograft rejection independent of an intact adaptive immune system. This is graphically illustrated by the findings that tissue and organ allografts are accepted indefinitely in SCID and rag-1 Ϫ/Ϫ mice that are NK replete but T and B lymphocyte deficient. This seemingly ancillary role for NK cells in transplant immunity makes defining their role in rejection difficult. However, there are a number of ways in which NK cells promote the adaptive immune response resulting in both acute and chronic allograft injury (illustrated in Figure 1 ).
NK cells have varied means of enhancing adaptive immunity 19 and probably can contribute to acute allograft rejection. 20 First, NK cells play an important role in "licensing" antigen- SPECIAL ARTICLE www.jasn.org presenting cells, especially DC, resulting in DC maturation and subsequent T cell activation. 21 Also, NK cells provide an early source of IFN-␥ that helps tailor the generation of Th-1-like immunity by CD4 T cells. 22, 23 NK cells also can augment CD4 T cell reactivity by a direct NK:CD4 T cell interaction. 24 All of these activities contribute to potentially graft-destructive acute T cell reactivity. Although NK cells are rarely demonstrated to be necessary for the rejection of solid-organ allografts, there are exceptions. It is interesting that NK cells are required to trigger rejection of cardiac allografts in CD28 Ϫ/Ϫ recipients, and this response requires the absence of self MHC expression by the graft, 25 ,26 a classic example of NK reactivity by the missingself concept.
NK cells have also been implicated in promoting chronic allograft injury. NK cells even infiltrate syngeneic kidney transplants after ischemic reperfusion injury and may contribute to chronic graft pathology. 27 Other studies suggest that NK cells can contribute to chronic allograft vasculopathy, possibly as a result of the missing-self MHC class I expression by allogeneic vascular endothelium on the transplant. 28, 29 Such NK-dependent injury is IFN-␥ dependent, 29 a finding that correlates with the requirement of conventional CD4 T cells to mediate acute cardiac allograft rejection by and IFN-␥-dependent mechanism. 30 Although it is not yet clear what molecular signals predominate the triggering of NK reactivity to allografts, this response is generally assumed to be harmful to graft survival.
AN UNEXPECTED CONTRIBUTION OF NK CELLS TO ALLOGRAFT TOLERANCE
Despite the ongoing correlation between NK cell reactivity and allograft rejection, it has become apparent that NK cells have important regulatory properties 31 that can actually facilitate allograft tolerance induction. 32, 33 We stumbled onto this unexpected property of NK cells by studying the nature of tolerance to pancreatic islet allografts after host treatment targeting either CD154 or CD11a (LFA-1). 32 Because CD8 T cells have been shown to constitute a barrier to allograft tolerance induction after co-stimulation blockade, 14, 34 we set out to study the propensity for tolerance induction in MHC class I-deficient, ␤-2 microglobulin (␤2m) knockout mice. Such animals are deficient in generalized MHC class I-dependent immunity, including CD8 T cells. 35 To our surprise, tolerance induction absolutely required an intact host MHC class I pathway in that ␤2m-deficient hosts were completely resistant to induced allograft tolerance. 32 Because NKT cells restricted to nonclassical MHC class I CD1 molecules have been implicated in allograft tolerance induction, 36 -38 it was possible that this alternate ␤2m-dependent pathway was required for tolerance. However, NKT cell-deficient CD1-knockout mice were completely amenable to allograft tolerance induction, 32 a finding consistent with another similar study. 33 NK1.1 ϩ cells that were present in CD1-knockout mice were found to be required for allograft tolerance, leading to the conclusion that NK cells, not NKT cells, were required for at least some forms of allograft tolerance induction. 32, 33 
WHAT ARE THE CELLULAR TARGETS OF NK CELL-MEDIATED IMMUNE REGULATION?
An ongoing question will center on identifying the cellular targets of NK cells that result in tolerance induction. Both antigen-presenting cells (APC) and T cells themselves are potential objects of NK cell regulation. There is clear precedence for DC being regulated by NK cells. Although NK cells can certainly drive DC maturation, there is an important alternative outcome of this NK interaction, resulting in the killing of the immature DC. 9,10 It is not yet clear which factors are critical for directing a positive versus negative impact of NK cells on immature DC. One straightforward pathway of NK cell regulation of alloimmunity can be found in the direct elimination of donorderived DC as a result of the missing-self property of MHC-disparate allografts. Yu et al. 33 found that host NK cells rapidly destroyed MHC-disparate allogeneic DC but that semiallogeneic DC (i.e., host ϫ donor F1 cells) were protected from such regulation (Figure 2 ). The result of rapidly eliminating donor DC would be the blunting of the "direct" (donor APC-dependent) response 33 that accounts for the high frequency of alloreactive cells found in the native T cell repertoire. Thus, NK cells may essentially prune the magnitude of this direct antidonor reactivity by simply eliminating the primary donor-derived DC that are involved in activating the response. Alternatively, the extent of NK regulation of recipient DC that are involved in "indirect" (host APC-dependent) allograft antigen presentation is an important issue that is currently undefined.
Although such allogeneic DC elimination by NK cells can occur, this activity alone probably does not account for the entire role for NK cells in allograft tolerance. If the sole property of NK cells is to eliminate donor DC via a missing-self response, then semiallogeneic allografts bearing self class I molecules should be protected from such donor DC elimination 33 and so render the host resistant to tolerance induction. However, we find that recipients can be readily tolerized to (donor ϫ host)F1 allografts, 32 suggesting that the role for NK cells in tolerance is more complex. An alternate view is that activated T cells themselves may serve as proximal targets of NK cell-mediated regulation (Figure 3 ). For example, the NK activating ligand MHC class I-related chain A can be induced on stimulated human T cells, serving as a potential target of the corresponding activating NKG2D receptor. Importantly, such cellular "stress" signals on mouse T cells can make them vulnerable to NK killing despite autologous MHC class I expression. 11 This illustrates the issue raised that NK cells actually integrate both stimulating and inhibitory signals to determine the outcome of the NK response. It is intriguing that this NK killing of autologous stressed T cells was found to be perforin dependent, 11 consistent with our own findings that tolerance induction to islet allografts was both perforin and NK cell dependent in vivo. 32 Thus, in the presence of a tolerizing regimen, it is conceivable that the partial or inappropriate activation of host alloreactive T cells results in the upregulation of their NK activating ligands, thereby increasing their vulnerability to NK cell-mediated killing. Further studies clearly will be necessary to test this proposition.
We believe that DC and T cells are major candidate targets of NK cell-mediated immune regulation. Of course, these are not mutually exclusive pathways; NK cells may indeed directly regulate both DC and T cells during tolerance induction. It remains to be determined whether other types of myeloid lineage cells or lymphocytes (e.g., B cells) may also be involved in NK cell regulatory activity. Clearly, it will be important to clarify the pathways required for beneficial NK cell reactivity in allograft tolerance induction. Also, it is not known exactly which type of NK cell may be involved in promoting allograft tolerance. For example, there has been a newly described "bitypic" NK-like DC (NK/DC) implicated in the regulation of autoimmunity. 39 Such cells can function in a veto-like capacity by regulating T cells that interact with this cell. It is difficult to imagine how such NK/DC can directly regulate donor-type DC as described above, but the potential role of this unusual cell type in regulating allograft immunity must be considered in future studies.
WHAT IS THE RELATIONSHIP BETWEEN NK CELL AND REGULATORY T CELL REACTIVITY IN ALLOGRAFT TOLERANCE?
There has been a tremendous resurgence in the interest in regulatory T cells (Treg) in the maintenance of allograft tolerance (reviewed by Wood et al., 40 Waldmann et al., 41 and Walsh et al. 42 ). Although this discussion largely centers on MHC class I-dependent reactivity, it is important to emphasize that induced allograft tolerance is generally dependent on CD4 T cells. An unanswered question is whether there is a direct connection between NK cell function and Treg activity in the promotion of allograft tolerance. To date, most published evidence favors the contrary notion that there is mutual antagonism between NK cells and Treg. 43 The regulatory potential of NK cells is only one facet of a growing body of evidence indicating that several immune pathways that are regarded as graft destructive can also participate in tolerance induction. Generally, the presence of proinflammatory immunity and cytolytic activity clearly correlates with allograft injury. However, it is becoming increasingly apparent that there is also a major regulatory role for many of these same effector cells and molecules, including IFN-␥, perforin, and NK cells. Regarding IFN-␥, there are clear examples where this cytokine can be essential for either CD4 30 or CD8 46 T cell-mediated acute rejection and also for chronic rejection. 29 However, there is clearly another side to IFN-␥ that can promote allograft survival and tolerance. IFN-␥ can actually have an early protective effect on allograft injury. 47 Also, several studies show a major role for IFN-␥ in promoting allograft tolerance 48 -50 and may even play an important role in ongoing allograft tolerance activity mediated by Treg. 50 The cytolytic mediator perforin also demonstrates a marked "duality" in promoting either allograft rejection or tolerance. Although gene expression for the cytolytic mediators perforin and granzymes clearly correlates with graft rejection, [51] [52] [53] perforin is also necessary for tolerance induction. 32, 54 The exact role for perforin in tolerance is not yet clear, but cytolytic molecules such as perforin 55 and granzymes 56 have been implicated in the function of Treg. Although cytotoxic activity by Treg has been clearly demonstrated, our own results suggest that this is not required for long-term allograft survival. We found that the transfer of perforin-replete NK cells was sufficient to restore long-term allograft survival to otherwise perforindeficient mice, 32 arguing against an obligate role for perforin expression by conventional T cells for graft survival.
This last point may help to resolve the seeming paradox between both destructive and protective properties of these effector molecules on allograft survival. It is highly likely that these "proinflammatory" pathways are compartmentalized by cell type and/or by anatomic location to promote graft injury or survival, respectively. For example, alloreactive effector T cells expressing IFN-␥ and perforin may well mediate acute or chronic graft injury. However, Treg and NK cells may use these same pathways to mediate the regulation of alloimmunity. It will be an ongoing challenge to sort out the opposing roles of these effector pathways in allograft immunity and tolerance and to translate this information into clinically relevant therapeutic strategies to promote allograft survival.
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